MedPageToday -- Gene therapy appears to have long-term success for treating X-linked severe combined immunodeficiency disease (SCID) -- but recipients are at risk for acute leukemia, according to a small study from France.
MedPageToday -- Gene therapy appears to have long-term success for treating X-linked severe combined immunodeficiency disease (SCID) -- but recipients are at risk for acute leukemia, according to a small study from France.
